3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gynecologic
1
Conditions
Weight Loss
1
Ovarian Neoplasms
1
Osteochondroma
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Nevus, Epithelioid and Spindle Cell
1
Malnutrition
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioblastoma
1
Giant Cell Tumors
1
Gastrointestinal Neoplasms
1
Fibrosis
1
Endometrial Neoplasms
1
Endometrial Hyperplasia
1
Carcinoma, Lobular
1
Carcinoma in Situ
1
Barrett Esophagus
1
Interventions
Tirzepatide
9
Exercise
5
Counseling
4
semaglutide
3
Resistance Training
3
Methods
3
Tablets
2
Standard of Care
2
Specimen Handling
2
Progestins
2
Nutrition Assessment
2
Megestrol Acetate
2
Diet Therapy
2
mirabegron
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
atezolizumab
1
Weights and Measures
1
Walk Test
1
Vitamin D
1
Urine Specimen Collection
1
Trehalase
1
Topiramate
1
Therapeutics
1
TIC10 compound
1
Surveys and Questionnaires
1
Stents
1
Spermine Synthase
1
Sampling Studies
1
Qsymia
1
Psychology, Positive
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Obesity
×
Sampling Studies
×
1 year
×
Clear all
NCT03027479
2025-12-22
METERMUS-IMC
University Hospital, Tours
Phase NA
Completed
70 enrolled